EXACT Sciences Corp (EXAS)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
SERVICES-MEDICAL LABORATORIES
CEO:
Kevin T. Conroy
Employees:
1,977
441 CHARMANY DRIVE, MADISON, WI 53719
608-284-5700

EXACT Sciences Corp. is a molecular diagnostics company, which is focused on the early detection and prevention of colorectal cancer. It has an intellectual property, which protects its non invasive, molecular screening technology for the detection of colorectal cancer. The company was founded on February 10, 1995 and is headquartered in Madison, WI.

Data derived from most recent annual or quarterly report
Market Cap 8.681 Billion Shares Outstanding174.117 Million Avg 30-day Volume 2.443 Million
P/E Ratio0.0 Dividend Yield0.0 EPS-1.35
Price to Revenue6.5864 Debt to Equity0.725 EBITDA-540.562 Million
Price to Book Value3.7429 Operating Margin-39.5405 Enterprise Value13.741 Billion
Current Ratio2.527 EPS Growth0.081 Quick Ratio2.126
1 Yr BETA 1.4228 52-week High/Low 133.99 / 46.15 Profit Margin-40.2574
Operating Cash Flow Growth-282.2143 Altman Z-Score1.7037 Free Cash Flow to Firm -845.818 Million
Earnings Report2022-07-27
View SEC Filings from EXAS instead.

View recent insider trading info

Funds Holding EXAS (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding EXAS BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

CONROY KEVIN T PRESIDENT AND CEO

  • Officer
  • Director
1,539,084 2022-03-17 13

DOYLE JAMES EDWARD

  • Director
48,307 2022-03-17 4

COWARD D SCOTT CHIEF LEGAL OFFICER

  • Officer
43,836 2022-02-28 5

ELLIOTT JEFFREY THOMAS CHIEF FINANCIAL OFFICER

  • Officer
46,932 2022-02-28 8

CONDELLA SARAH EVP, HUMAN RESOURCES

  • Officer
181,618 2022-02-28 7

ORVILLE JACOB A GENERAL MANAGER, NEW VENTURES

  • Officer
31,166 2022-02-25 5

CUNNINGHAM EVERETT CHIEF COMMERCIAL OFFICER

  • Officer
30,711 2022-02-25 2

ZANOTTI KATHERINE S

  • Director
59,537 2021-07-30 3

LEVANGIE DANIEL J

  • Director
17,691 2021-06-30 1

CLANCY PAUL J

  • Director
5,496 2021-06-30 1

LEWIS-HALL FREDA C

  • Director
10,483 2021-06-30 1

PETROVIC SHACEY

  • Director
8,357 2021-06-30 1

SEBELIUS KATHLEEN

  • Director
13,877 2021-06-30 1

JACQUET PIERRE

  • Director
11,753 2021-06-30 1

CAREY THOMAS D.

  • Director
5,292 2021-06-02 1

LIDGARD GRAHAM PETER CHIEF SCIENCE OFFICER

  • Officer
60,061 2021-03-11 0

WYZGA MICHAEL S

  • Director
2,558 2021-02-26 0

HOOF TORSTEN GENERAL MANAGER, INTERNATIONAL

  • Officer
2,017 2020-09-24 0

SLAVITT ANDREW M

  • Director
9,445 2020-07-23 0

CASDIN ELI

  • Director
9,270 2020-07-23 0

PAULSEN GISELA GEN MGR, PRECISION ONCOLOGY

  • Officer
0 2020-04-20 0

STENHOUSE MARK PRESIDENT, COLOGUARD

  • Officer
29,926 2020-04-02 0

COLE G BRADLEY GENERAL MANAGER - DIAGNOSTICS

  • Officer
10,194 2020-02-19 0

JOHNSON SCOTT C. SVP - RESEARCH AND DEVELOPMENT

  • Officer
12,504 2019-09-11 0

HOOKER ANA SVP, OPERATIONS

  • Officer
76,474 2019-04-24 0

THOMPSON DAVID

  • Director
166,671 2018-12-31 0

FALLON JOHN A.

  • Director
33,767 2018-07-30 0

ARORA MANEESH COO

  • Officer
  • Director
658,613 2018-03-09 0

STERLING LIONEL

  • Director
127,575 2017-07-27 0

BAKEWELL JOHN K CHIEF FINANCIAL OFFICER

  • Officer
0 2016-01-01 0

MEGAN WILLIAM J. SVP, FINANCE

  • Officer
52,369 2015-08-26 0

CRAWFORD SALLY

  • Director
212,341 2014-10-16 0

CONNELLY JAMES P

  • Director
80,513 2013-08-27 0

STOLTENBERG LAURA S CHIEF COMMERCIAL OFFICER

  • Officer
27,273 2013-03-19 0

KRAYACICH JOHN M SVP, SALES AND MARKETING

  • Officer
4,500 2011-03-15 0

BERGER BARRY M SVP, CHIEF MEDICAL OFFICER

  • Officer
60,552 2010-01-07 0

MCGILLICUDY CORNELIUS III

  • Director
97,274 2009-07-20 0

ZENNER PATRICK J

  • Director
124,994 2009-07-20 0

WILLSEY LANCE

  • Director
78,033 2009-07-20 0

KANIA EDWIN M JR

  • Director
1,375,290 2009-07-20 0

LUBER JEFFREY R PRESIDENT AND CEO

  • Officer
  • Director
0 2009-03-31 0

CARELLI CHARLES R JR SVR, CFO, TREASURER & SECRETAR

  • Officer
0 2009-03-31 0

SINGER MICHAEL E

  • Director
540,193 2008-12-12 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
EXACT SCIENCES CORP EXAS 2022-05-26 22:15:03 UTC 0.57 0.25 1600000
EXACT SCIENCES CORP EXAS 2022-05-26 21:45:03 UTC 0.57 0.25 1600000
EXACT SCIENCES CORP EXAS 2022-05-26 21:15:03 UTC 0.57 0.25 1600000
EXACT SCIENCES CORP EXAS 2022-05-26 20:45:03 UTC 0.57 0.25 1600000
EXACT SCIENCES CORP EXAS 2022-05-26 20:15:03 UTC 0.57 0.25 1600000
EXACT SCIENCES CORP EXAS 2022-05-26 19:45:03 UTC 0.57 0.25 1600000
EXACT SCIENCES CORP EXAS 2022-05-26 19:15:03 UTC 0.57 0.25 1600000
EXACT SCIENCES CORP EXAS 2022-05-26 18:45:04 UTC 0.57 0.25 1600000
EXACT SCIENCES CORP EXAS 2022-05-26 18:15:03 UTC 0.57 0.25 1600000
EXACT SCIENCES CORP EXAS 2022-05-26 17:45:03 UTC 0.57 0.25 1600000
EXACT SCIENCES CORP EXAS 2022-05-26 17:15:03 UTC 0.57 0.25 1600000
EXACT SCIENCES CORP EXAS 2022-05-26 16:45:04 UTC 0.5363 0.2837 1600000
EXACT SCIENCES CORP EXAS 2022-05-26 16:15:03 UTC 0.5363 0.2837 1600000
EXACT SCIENCES CORP EXAS 2022-05-26 15:45:03 UTC 0.5363 0.2837 1600000
EXACT SCIENCES CORP EXAS 2022-05-26 15:15:03 UTC 0.5363 0.2837 1600000
EXACT SCIENCES CORP EXAS 2022-05-26 14:45:03 UTC 0.5253 0.2947 1600000
EXACT SCIENCES CORP EXAS 2022-05-26 14:15:03 UTC 0.5253 0.2947 1600000
EXACT SCIENCES CORP EXAS 2022-05-26 13:45:05 UTC 0.5253 0.2947 1600000
EXACT SCIENCES CORP EXAS 2022-05-26 13:15:03 UTC 0.5253 0.2947 1600000
EXACT SCIENCES CORP EXAS 2022-05-26 12:45:03 UTC 0.5253 0.2947 1600000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
American Century Quantitative Equity Funds, Inc.- AC Alternatives Equity Market Neutral Fund EXAS -1107.0 shares, $-102375.36 2019-12-31 N-PORT
American Century Quantitative Equity Funds, Inc.- AC Alternatives Disciplined Long Short Fund EXAS -613.0 shares, $-56690.24 2019-12-31 N-PORT
AGF Investments Trust- AGFIQ U.S. Market Neutral Value Fund EXAS -40.0 shares, $-4078.0 2020-09-30 N-PORT
Jackson Variable Series Trust- JNL/Nicholas Convertible Arbitrage Fund EXAS -15870.0 shares, $-920460.0 2020-03-31 N-PORT
Advisors Series Trust- Pzena Long/Short Value Fund EXAS -1622.0 shares, $-139297.36 2020-05-31 N-PORT
FundVantage Trust- Gotham Defensive Long Fund EXAS -7.0 shares, $-406.0 2020-03-31 N-PORT
AQR Funds- AQR Large Cap Relaxed Constraint Equity Fund EXAS -857.0 shares, $-77447.09 2019-09-30 N-PORT
FundVantage Trust- Gotham Master Neutral Fund EXAS -42.0 shares, $-4281.9 2020-09-30 N-PORT
RUSSELL INVESTMENT CO- U.S. Dynamic Equity Fund EXAS -1204.0 shares, $-165140.64 2021-01-31 N-PORT
JNL Series Trust- JNL/AQR Large Cap Relaxed Constraint Equity Fund EXAS -2230.0 shares, $-293869.4 2021-03-31 N-PORT
TIFF INVESTMENT PROGRAM- TIFF Multi-Asset Fund EXAS -7369.0 shares, $-573529.27 2021-12-31 N-PORT
FORUM FUNDS- ABSOLUTE CONVERTIBLE ARBITRAGE FUND EXAS -18600.0 shares, $-1447638.0 2021-12-31 N-PORT
AMERICAN BEACON FUNDS- American Beacon SSI Alternative Income Fund EXAS -4244.0 shares, $-330310.52 2021-12-31 N-PORT
Guidestone Funds- Strategic Alternatives Fund EXAS -2173.0 shares, $-169124.59 2021-12-31 N-PORT
Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund EXAS -3200.0 shares, $-249056.0 2021-12-31 N-PORT
AQR Funds- AQR Alternative Risk Premia Fund EXAS -3875.0 shares, $-301591.25 2021-12-31 N-PORT
Morningstar Funds Trust- Morningstar Alternatives Fund EXAS -4407.0 shares, $-336518.52 2022-01-31 N-PORT
NORTHERN LIGHTS FUND TRUST II- Invenomic Fund EXAS -11147.0 shares, $-851184.92 2022-01-31 N-PORT
VANGUARD TRUSTEES' EQUITY FUND- VANGUARD ALTERNATIVE STRATEGIES FUND EXAS -1261.0 shares, $-96289.96 2022-01-31 N-PORT
Series Portfolios Trust- Weiss Alternative Multi-Strategy Fund EXAS -619.0 shares, $-47266.84 2022-01-31 N-PORT
Principal Funds, Inc- Global Multi-Strategy Fund EXAS 1210.0 shares, $-94452.6 2022-02-28 N-PORT
RBB Fund, Inc.- Boston Partners Global Long/Short Fund EXAS -4095.0 shares, $-319655.7 2022-02-28 N-PORT
RBB Fund, Inc.- Boston Partners Long/Short Research Fund EXAS -11247.0 shares, $-877940.82 2022-02-28 N-PORT
GMO TRUST- GMO Strategic Opportunities Allocation Fund EXAS -3800.0 shares, $-296628.0 2022-02-28 N-PORT
GMO TRUST- GMO Implementation Fund EXAS -74900.0 shares, $-5846694.0 2022-02-28 N-PORT
GMO TRUST- GMO Benchmark-Free Fund EXAS -28700.0 shares, $-2240322.0 2022-02-28 N-PORT
GMO TRUST- GMO Alternative Allocation Fund EXAS -5100.0 shares, $-398106.0 2022-02-28 N-PORT
AQR Funds- AQR Multi-Asset Fund EXAS -2190.0 shares, $-170447.7 2021-12-31 N-PORT
PACE SELECT ADVISORS TRUST- PACE Alternative Strategies Investments EXAS -9555.0 shares, $-729619.8 2022-01-31 N-PORT
INVESTMENT MANAGERS SERIES TRUST- 361 Global Long/Short Equity Fund EXAS -86956.0 shares, $-6639960.16 2022-01-31 N-PORT
First Trust Exchange-Traded Fund III- First Trust Long/Short Equity ETF EXAS -8371.0 shares, $-639209.56 2022-01-31 N-PORT
Columbia Funds Series Trust I- Multi-Manager Directional Alternative Strategies Fund EXAS -11472.0 shares, $-876001.92 2022-01-31 N-PORT
Columbia Funds Series Trust I- Multi-Manager Directional Alternative Strategies Fund EXAS -11472.0 shares, $-876001.92 2022-01-31 N-PORT
RUSSELL INVESTMENT CO- Sustainable Equity Fund EXAS -3332.0 shares, $-254431.52 2022-01-31 N-PORT
FundVantage Trust- Gotham Hedged Plus Fund EXAS -2703.0 shares, $-188993.76 2022-03-31 N-PORT
AdvisorShares Trust- AdvisorShares Dorsey Wright Short ETF EXAS -3891.0 shares, $-272058.72 2022-03-31 N-PORT
Federated Hermes Adviser Series- Federated Hermes MDT Market Neutral Fund EXAS -3219.0 shares, $-225072.48 2022-03-31 N-PORT

Elevate your investments